Skip to main content

Advertisement

Table 1 Patient access schemes in the Asia-Pacific region by country, type and condition

From: Patient access schemes in Asia-pacific markets: current experience and future potential

  Australia South Korea New Zealand Total
Types     
  Outcome-based 21 - - 21
  Evidence generation 3 - - 3
  Financially-based 33 3 5 41
  Hybrid* 41 - - 41
Conditions
  Cancer 29 - 2 31
  Inflammatory Conditions 28 - 1 29
  Infectious Disease 7 - - 7
  Pulmonary Hypertension 7 1 1 9
  Other 27 2 1 30
Technology
  Pharmaceuticals 95 3 5 103
  Medical devices 3 - - 3
Subtotal 98 3 5 106
  1. *Hybrid schemes involved both pricing arrangements and conditional treatment continuation